Institutional investors

A major player in private equity and infrastructure

20 years’ experience servicing institutional investors

  • A range of investment vehicles and expertise in dedicated mandates for major European institutional investors
  • Extensive coverage of all aspects of private equity
  • Stable, first-rate performance

Differentiated deal flow

  • Over 1,000 qualified projects reviewed per year
  • A long-term proprietary network thanks to the team’s recognized know-how
  • Strong regional roots allowing unrivalled access to primary transactions

A personalised relationship and active support

  • A unique client focus strategy
  • Close relationship with fund managers
  • A dedicated platform for each investor
Expertises
Omnes Capital supports companies at every stage of their growth, from start-ups to mature businesses
NewsRoom
Publication
Omnes Newsletter no 32: Philippe Barre, Founder of Darwin
Press release
11 April 2019
NH TherAguix, a start-up specializing in nanomedicine for cancer radiotherapy, announces a €13 million round of fundraising, led by Bpifrance

NH TherAguix, a start-up specializing in nanomedicine for cancer radiotherapy, announces a €13 million round of fundraising, led by Bpifrance
Press release
09 April 2019
Appointments within Omnes: Omnes welcomes five newcomers as Director, Principal, Analyst, Middle Office Managers, and promotes four Principals
Appointments within Omnes: Omnes welcomes five newcomers as Director, Principal, Analyst, Middle Office Managers, and promotes four Principals
Press release
03 April 2019
AgomAb Therapeutics Completes Euros 21m Series A Financing
AgomAb Therapeutics Completes Euros 21m Series A Financing
Publication
Omnes Newsletter no 32: VC news H2 2017
Press release
19 March 2019
Omnes announces a 15% investor net IRR on its Capenergie 2 fund, focused on renewable energy

Omnes announces a 15% investor net IRR on its Capenergie 2 fund, focused on renewable energy

Pages